MedGenome launches VarMiner to detect genetic variants for rare diseases and inherited cancers

The software can predict and rank a pathogenic variant in 90 per cent of rare diseases cases with no or minimum manual intervention

To improve diagnostic results in South Asia, MedGenome Labs has developed and launched VarMiner, an AI-enabled powerful variant interpretation software suite. This proprietary software will help clinicians, molecular geneticists, and Genome analysts to interpret and report actionable variants.

VarMiner supports various NGS Dx workflows

• Germline Analysis: Covers all rare diseases, inherited cancers, Mitochondrial genome analysis, PGx and HLA analysis
• Carrier/TRIO Analysis: Combined Analysis of familial samples to detect De-novo and common inherited variants and reporting
• Somatic Analysis: Comprehensive analysis of cancer genomes with support for Liquid Biopsy, Hematology and Solid tumour cases

VarMiner as an tool detects genomic variants in all rare diseases, inherited cancers, as well as conducts mitochondrial genome analysis, PGx and HLA analysis.